Mono Pharmacare Limited (NSE: MONOPHARMA), ISIN INE0OIP01012 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
MONOPHARMA last traded at ₹10.00 (-4.76%), with a 52-week range of ₹9.45 to ₹27.50 (as of 29 Jul 2026).
Shareholding as of Mar 2026: promoters 56.72%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 35/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.